OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
Wei Du, Lin Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Wei Du, Lin Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
Qingdan Liu, MeiLan K. Han, Meilan Li, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Qingdan Liu, MeiLan K. Han, Meilan Li, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease
Yamei Li, Ping Qi, Siyuan Song, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116585-116585
Open Access | Times Cited: 5
Yamei Li, Ping Qi, Siyuan Song, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116585-116585
Open Access | Times Cited: 5
Differential levels of thyroid hormones, cortisol, and apolipoprotein M in fatty liver disease
Amir Mohammad Zargar, Heidar Tavilani, Maryam Hasanzarrini, et al.
Hormone Molecular Biology and Clinical Investigation (2025)
Closed Access
Amir Mohammad Zargar, Heidar Tavilani, Maryam Hasanzarrini, et al.
Hormone Molecular Biology and Clinical Investigation (2025)
Closed Access
Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases
Marianna Danielli, Róisín Clare Thomas, Lauren M. Quinn, et al.
VASA (2022) Vol. 51, Iss. 6, pp. 341-350
Closed Access | Times Cited: 15
Marianna Danielli, Róisín Clare Thomas, Lauren M. Quinn, et al.
VASA (2022) Vol. 51, Iss. 6, pp. 341-350
Closed Access | Times Cited: 15
Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach
Tengda Huang, Dawei Zheng, Yujia Song, et al.
Medicine (2023) Vol. 102, Iss. 35, pp. e34570-e34570
Open Access | Times Cited: 8
Tengda Huang, Dawei Zheng, Yujia Song, et al.
Medicine (2023) Vol. 102, Iss. 35, pp. e34570-e34570
Open Access | Times Cited: 8
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 13
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 13
Empagliflozin ameliorates liver fibrosis in NASH rat model via targeting hepatic NF-κB/SOX9/OPN signaling and osteocalcin level
Mohamed M. Elseweidy, Abdelmoneim A. Ali, Sara M. Hassanin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3449-3459
Open Access | Times Cited: 7
Mohamed M. Elseweidy, Abdelmoneim A. Ali, Sara M. Hassanin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 3449-3459
Open Access | Times Cited: 7
α-Lipoic acid – a promising agent for attenuating inflammation and preventing steatohepatitis in rats fed a high-fat diet
Mateusz Zwierz, Adrian Chabowski, Klaudia Sztolsztener
Archives of Biochemistry and Biophysics (2023) Vol. 750, pp. 109811-109811
Open Access | Times Cited: 6
Mateusz Zwierz, Adrian Chabowski, Klaudia Sztolsztener
Archives of Biochemistry and Biophysics (2023) Vol. 750, pp. 109811-109811
Open Access | Times Cited: 6
Exploring the effects of environmentally relevant concentrations of tris(2-chloroethyl) phosphate on tadpole health: A comprehensive analysis of intestinal microbiota and hepatic transcriptome
Zi-Ying Wang, Wen-Qi Xie, Zi-Yong Xiang, et al.
The Science of The Total Environment (2024) Vol. 946, pp. 174428-174428
Closed Access | Times Cited: 2
Zi-Ying Wang, Wen-Qi Xie, Zi-Yong Xiang, et al.
The Science of The Total Environment (2024) Vol. 946, pp. 174428-174428
Closed Access | Times Cited: 2
Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
Jaehyun Bae, Byung‐Wan Lee
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1506-1506
Open Access | Times Cited: 6
Jaehyun Bae, Byung‐Wan Lee
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1506-1506
Open Access | Times Cited: 6
Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease
Zhen Li, Hao Ouyang, Junfeng Zhu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Zhen Li, Hao Ouyang, Junfeng Zhu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Liver Regeneration in Acute on Chronic Liver Failure
Madelyn J. Blake, Clifford J. Steer
Clinics in Liver Disease (2023) Vol. 27, Iss. 3, pp. 595-616
Closed Access | Times Cited: 4
Madelyn J. Blake, Clifford J. Steer
Clinics in Liver Disease (2023) Vol. 27, Iss. 3, pp. 595-616
Closed Access | Times Cited: 4
Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Mohammadjavad Sotoudeheian
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 290-304
Closed Access | Times Cited: 1
Mohammadjavad Sotoudeheian
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 290-304
Closed Access | Times Cited: 1
Taurine alleviated hepatic steatosis in oleic acid-treated-HepG2 cells and rats fed a high-fat diet
Qi Song, Jun xia Guo, Y F Xun, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16401-e16401
Open Access | Times Cited: 3
Qi Song, Jun xia Guo, Y F Xun, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16401-e16401
Open Access | Times Cited: 3
Pyroptosis is involved in maternal nicotine exposure‐induced metabolic associated fatty liver disease progression in offspring mice
Yu‐Qing Su, Yan Lin, S. Huang, et al.
Molecular Reproduction and Development (2023) Vol. 91, Iss. 8
Open Access | Times Cited: 3
Yu‐Qing Su, Yan Lin, S. Huang, et al.
Molecular Reproduction and Development (2023) Vol. 91, Iss. 8
Open Access | Times Cited: 3
Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, et al.
Cureus (2023)
Open Access | Times Cited: 2
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, et al.
Cureus (2023)
Open Access | Times Cited: 2
Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes
Nan Zhu, Yongfeng Song, Chen Zhang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Nan Zhu, Yongfeng Song, Chen Zhang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes
Yu-Jie Wang, Chunhua Jin, Jiang-Feng Ke, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3717-3728
Open Access | Times Cited: 3
Yu-Jie Wang, Chunhua Jin, Jiang-Feng Ke, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3717-3728
Open Access | Times Cited: 3
Insilico Studies Unveiling the Hepatoprotective Potential of Morus alba Linn: Docking and ADMET Analysis
Abha Lichade, A. J. Deshmukh, Yashwant Nakhate, et al.
International Journal of Ayurvedic Medicine (2024) Vol. 15, Iss. 2, pp. 444-451
Open Access
Abha Lichade, A. J. Deshmukh, Yashwant Nakhate, et al.
International Journal of Ayurvedic Medicine (2024) Vol. 15, Iss. 2, pp. 444-451
Open Access
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Pranali Jadhav, Asha Thomas, Vinay M. Chopada, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
Pranali Jadhav, Asha Thomas, Vinay M. Chopada, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access
Selective Modulation of Aryl Hydrocarbon Receptor by Coptisine in MAFLD
Xiliang Zhu, Qi Liu, Zhaoyun Cheng, et al.
Research Square (Research Square) (2024)
Open Access
Xiliang Zhu, Qi Liu, Zhaoyun Cheng, et al.
Research Square (Research Square) (2024)
Open Access
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
Qingdan Liu, MeiLan K. Han, Meilan Li, et al.
Research Square (Research Square) (2023)
Open Access
Qingdan Liu, MeiLan K. Han, Meilan Li, et al.
Research Square (Research Square) (2023)
Open Access
